EDIT vs NWS · rev $32.3M vs rev $9.03B
Editas Medicine Inc (EDIT) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
NWS (NWS) common stock.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
EDIT currently screens at market cap $375.2M. NWS currently screens at market cap $0.
Not investment advice. Open the EDIT and NWS stock pages for the full models.
Not investment advice.